SARAH HANSON: Open Payments
NPI 1982856837 · LOWELL, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,532 in 146 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $1,424 · 2025 $2,532
Food & beverage: $2,532
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $258 |
| Novo Nordisk Inc | 16 | $245 |
| AstraZeneca Pharmaceuticals LP | 9 | $239 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $224 |
| Viatris Specialty LLC | 8 | $165 |
| Lilly USA, LLC | 10 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $155 |
| Lundbeck LLC | 8 | $141 |
| PFIZER INC. | 11 | $137 |
| Amgen Inc. | 8 | $134 |
Products named: Kerendia, YUPELRI, CAPLYTA, QULIPTA, REXULTI, FARXIGA, Wegovy, Ozempic.
Industry payments across AR — which companies pay providers there.
